NUS - NYSE

Nu Skin Enterprises, Inc.

NUS·NYSE

$5.28

-5.7%

Consumer DefensiveHousehold & Personal Products

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$256.35M

EPS3.2500

P/E Ratio1.62

Earnings Date08/06/2026

1.41B

Assets

-4%

3Y-23.0%

5Y-28.0%

10Y-5.0%

600.07M

Total Liabilities

-27%

3Y-35.0%

5Y-44.0%

10Y-26.0%

805.24M

Total Equity

24%

3Y-10.0%

5Y-10.0%

10Y+21.0%

Nu Skin Enterprises, Inc. Funding & Solvency Profile

NUS · NYSE

Current Assets

Cash & Cash Equivalents238.63M

Net Receivables39.54M

Inventory178.64M

Other Current Assets89.67M

Total Current Assets548 M

Non-Current Assets

Property, Plant & Equipment451.19M

Goodwill & Intangible Assets126.24M

Long-Term Investments18.75M

Other Non-Current Assets261.44M

Total Non-Current Assets731 M

Total Assets

1.41B

Financial Health Analysis

Current Ratio

2.08x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.75x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

284 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

39% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Nu Skin Enterprises, Inc. Balance Sheet

NUS • NYSE

Nu Skin Enterprises, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	238.6M	186.9M	256.1M	264.7M	339.6M	402.7M	335.6M	386.9M	426.4M	357.2M	289.4M	288.4M	525.2M	320M	273M	230.3M	158M	114.6M	87.3M	121.4M
Short-Term Investments	1.2M	11.1M	11.8M	13.8M	15.2M	21.2M	8.4M	11.3M	11.8M	10.9M	14.4M	11.8M	22M	13.4M	17.7M	0.0	0.0	0.0	5.2M	0.0
Cash & Short-Term Investments	239.8M	198M	267.8M	278.5M	354.8M	423.9M	344M	398.3M	438.2M	368.1M	303.7M	300.2M	547.1M	333.4M	290.7M	230.3M	158M	114.6M	92.6M	121.4M
Net Receivables	39.5M	50.8M	72.9M	47.4M	41.3M	63.4M	50.4M	53.3M	33.2M	31.2M	35.5M	35.8M	68.7M	36.9M	31.6M	25.7M	22.5M	16.5M	23.4M	19.4M
Accounts Receivables	39.5M	50.8M	72.9M	47.4M	41.3M	63.4M	50.4M	53.3M	33.2M	31.2M	35.5M	35.8M	68.7M	36.9M	31.6M	25.7M	22.5M	16.5M	23.4M	19.4M
Inventory	178.6M	190.2M	280M	346.2M	399.9M	314.4M	275.9M	295.8M	253.5M	249.9M	265.3M	338.5M	339.7M	135.9M	112.1M	114.5M	105.7M	114.4M	100.8M	92.1M
Prepaids	0.0	48.2M	44.1M	48.5M	44.5M	76.3M	45.3M	29.4M	34.5M	41M	72.7M	17.7M	20.9M	36.2M	62.8M	52M	51.7M	44.9M	49.6M	44.1M
Other Current Assets	89.7M	51.4M	37.1M	39.3M	32.4M	25.3M	24.5M	22.5M	18.4M	24M	29.2M	141.2M	140.9M	46.3M	32.9M	0.0	0.0	0.0	0.0	0.0
Total Current Assets	547.7M	538.6M	701.9M	759.9M	873M	903.2M	740.2M	799.2M	777.8M	714.3M	706.4M	834.7M	1.1B	599.4M	530.1M	422.5M	337.9M	290.4M	266.3M	277M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	451.2M	466.9M	523.1M	571.7M	598.2M	653.5M	644.8M	464.5M	464.6M	444.7M	454.5M	464.8M	396M	229.8M	149.5M	133.7M	79.4M	82.3M	88.5M	85.9M
Goodwill	83.6M	83.6M	230.8M	206.4M	206.4M	203M	196.6M	196.6M	115M	115M	112.4M	112.4M	112.4M	112.4M	112.4M	112.4M	112.4M	112.4M	112.4M	112.4M
Intangible Assets	42.6M	74.3M	105.3M	66.7M	77M	89.5M	80.3M	90M	67.6M	63.6M	67M	75.1M	83.2M	92.5M	83.3M	78.3M	82M	87.9M	86.2M	91.3M
Goodwill & Intangible Assets	126.2M	157.9M	336.1M	273.1M	283.4M	292.5M	276.9M	286.6M	182.6M	178.5M	179.5M	187.5M	195.6M	205M	195.8M	190.7M	194.4M	200.3M	198.6M	203.8M
Long-Term Investments	18.7M	39.6M	40.1M	39.5M	35.9M	11.3M	0.0	-37.3M	-33.8M	-35.8M	-40.4M	-15.1M	-5.2M	-26.3M	0.0	-45M	-49M	-66.4M	0.0	0.0
Tax Assets	0.0	174.2M	105.5M	89.8M	26.5M	35.4M	30.8M	37.3M	33.8M	35.8M	40.4M	15.1M	5.2M	26.3M	0.0	45M	49M	66.4M	60.1M	0.0
Other Non-Current Assets	261.4M	91.7M	99.8M	87M	89.5M	61.2M	76.3M	144.1M	164.9M	136.5M	165.5M	127.5M	111.1M	118.8M	115.6M	145.3M	136.7M	136.7M	69.7M	98.2M
Total Non-Current Assets	857.6M	930.3M	1.1B	1.1B	1B	1.1B	1B	895.2M	812.1M	759.7M	799.5M	779.8M	702.7M	553.5M	460.9M	469.7M	410.5M	419.4M	416.9M	387.9M
Total Assets	1.4B	1.5B	1.8B	1.8B	1.9B	2B	1.8B	1.7B	1.6B	1.5B	1.5B	1.6B	1.8B	1.2B	991M	892.2M	748.4M	709.8M	683.2M	664.8M
LIABILITIES
CURRENT LIABILITIES
Total Payables	33.5M	57M	64.4M	75.8M	81.1M	80.1M	68.6M	54.3M	63.4M	41.3M	28.8M	34.7M	82.7M	47.9M	44.8M	41.4M	30.9M	24.4M	27.2M	30.6M
Accounts Payable	26.2M	34.9M	43.1M	54M	50M	66.2M	39M	47.6M	50.3M	41.3M	28.8M	34.7M	82.7M	47.9M	32.2M	25.5M	25.3M	20.4M	24.1M	20.8M
Other Payables	7.3M	22.1M	21.2M	21.8M	31.1M	13.9M	29.7M	6.7M	13.1M	0.0	0.0	0.0	0.0	0.0	12.6M	15.9M	11.2M	8.1M	6.3M	19.5M
Accrued Expenses	0.0	152.1M	126.4M	198.7M	271M	214.8M	197.2M	196.2M	189.7M	151.6M	24.4M	29.2M	68.7M	51.7M	87M	146.1M	124.5M	115.8M	115.6M	120.1M
Short Term Debt	20M	30M	25M	25M	107.5M	30M	27.5M	69.5M	77.8M	82.7M	67.8M	82.8M	67.8M	39M	28.6M	27.9M	35.4M	30.2M	31.4M	26.7M
Capital Lease Obligations (Current)	18.4M	17.9M	23.9M	29.4M	33.4M	45M	39.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	22.1M	21.2M	21.8M	31.1M	58.9M	29.7M	45.4M	57.7M	31.7M	35.9M	32.2M	109.8M	23.6M	12.6M	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	15.7M	20.4M	27.1M	33.1M	35.1M	20.2M	20.1M	12.7M	13.5M	6.6M	6.2M	13.6M	4.6M	22M	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	191.8M	23.9M	68.8M	3.4M	3.5M	138M	3.9M	99.6M	103.7M	110M	279.9M	265.5M	544M	176.9M	58.8M	1M	-5.6M	-4.1M	-3.1M	-9.8M
Total Current Liabilities	263.7M	296.6M	328.9M	359.2M	529.7M	542.9M	356.8M	439.7M	447.4M	399M	407.6M	418.3M	776.8M	320.1M	241.2M	216.4M	185.2M	166.4M	171.2M	167.5M
NON-CURRENT LIABILITIES
Long Term Debt	261.8M	363.6M	478M	377.5M	268.8M	305.4M	334.5M	361M	310.8M	334.2M	181.7M	164.6M	113.9M	155M	107.9M	133M	121.1M	158.8M	169.2M	136.2M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-32.6M	-36.7M	-643K	6.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	310K	39.9M	522K	36M	24.2M	23.4M	27.9M	32.6M	36.7M	643K	16.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	10.2M	50.7M	96.7M	62.3M	77M	71.2M	68.9M	102.6M	127.1M	76.8M	90.9M	89.1M	71.8M	87.2M	67.6M	71.5M	66.4M	68.5M	67.8M	42.2M
Total Non-Current Liabilities	336.3M	520.9M	655.6M	564.4M	464M	519.9M	537M	472.9M	437.9M	411M	272.6M	253.7M	185.7M	242.2M	175.5M	204.5M	187.6M	227.2M	237.1M	178.3M
Capital Lease Obligations	82.4M	84.6M	104.3M	118.1M	127.5M	165M	145.1M	9.3M	10.3M	0.0	10.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	600.1M	817.5M	984.5M	923.7M	993.7M	1.1B	893.7M	912.6M	885.3M	810M	680.2M	672M	962.4M	562.3M	416.7M	421M	372.8M	393.6M	408.2M	345.9M
SHAREHOLDERS' EQUITY
Treasury Stock	-1.6B	-1.6B	-1.6B	-1.6B	-1.5B	-1.5B	-1.3B	-1.3B	-1.3B	-1.3B	-1B	-862.6M	-826.9M	-714.9M	-522.2M	-476.7M	-433.6M	-417M	-414M	-346.9M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122K	269K	0.0	228K	0.0	0.0	0.0	134K	61K	0.0	107K
Common Stock	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K
Additional Paid-In Capital	636M	627.8M	621.9M	613.3M	601.7M	579.8M	557.5M	552.6M	466.3M	439.6M	419.9M	414.4M	397.4M	317.3M	292.2M	256.5M	232.2M	218.9M	209.8M	199.3M
Retained Earnings	1.9B	1.7B	1.9B	1.9B	1.9B	1.8B	1.7B	1.6B	1.6B	1.6B	1.5B	1.4B	1.3B	1B	866.6M	749.9M	645.1M	584.2M	546.8M	531.6M
Accumulated Other Comprehensive Income/Loss	-116.1M	-124.8M	-100M	-86.5M	-73.9M	-64.8M	-85.3M	-79.9M	-66.3M	-84.1M	-71.3M	-51.5M	-46.2M	-51.8M	-62.6M	-58.5M	-68.1M	-70.1M	-67.8M	-65.1M
Total Stockholders' Equity	805.2M	651.5M	822M	897.3M	912.8M	894.3M	875.3M	781.9M	704.6M	664.1M	825.6M	942.4M	858.6M	590.6M	574.2M	471.2M	375.7M	316.2M	275M	319M
Total Equity	805.2M	651.5M	822M	897.3M	912.8M	894.3M	875.3M	781.9M	704.6M	664.1M	825.6M	942.4M	858.6M	590.6M	574.2M	471.2M	375.7M	316.2M	275M	319M
SUMMARY
Total Liabilities & Equity	1.4B	1.5B	1.8B	1.8B	1.9B	2B	1.8B	1.7B	1.6B	1.5B	1.5B	1.6B	1.8B	1.2B	991M	892.2M	748.4M	709.8M	683.2M	664.8M
Total Investments	20M	50.7M	51.9M	53.3M	51.1M	32.6M	8.4M	-26M	-21.9M	-24.9M	-26M	-3.3M	16.8M	13.4M	17.7M	-45M	-49M	-66.4M	5.2M	0.0
Total Debt	364.3M	478.2M	607.3M	520.5M	503.8M	500.4M	507M	430.5M	388.6M	416.9M	249.6M	247.3M	181.7M	194M	136.6M	160.9M	156.5M	189M	200.7M	162.8M
Net Debt	125.6M	291.3M	351.3M	255.8M	164.2M	97.7M	171.4M	43.6M	-37.8M	59.6M	-39.8M	-41.1M	-343.5M	-126M	-136.4M	-69.5M	-1.5M	74.4M	113.3M	41.5M
Shares Outstanding	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700	49,497,700

SEC Filings

NUS - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 29, 2026	May 28, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 08, 2026	May 06, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 08, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 03, 2026	May 28, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 27, 2026	March 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 20, 2026	March 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 09, 2026	March 05, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 13, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 12, 2026	February 12, 2026	2026	View Filing

Showing 1 to 10 of 472 filings

Related Guides

Blog Categories

Continue your NUS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.